|
SCIENTIFIC
PROGRAM
| Thursday,
February 17, 2000 |
| 14:15
- 16:00 |
HALL
A |
| |
S01: Plenary Session I:
NEW MECHANISMS OF ACTION
J.M. Dayer, Geneva, Switzerland
M. Feldmann, London, UK |
|
| 14:15 |
INDUCTION OF TRANSPLANTATION
TOLERANCE BY 1,25 DIHYDROXYVITAMIN D3 AND ITS ANALOGUES
L. Adorini, Milano, Italy |
|
| 14:35 |
IMMUNOSUPPRESSION IN CHRONIC
INFLAMMATION
J-M. Dayer, Geneva, Switzerland |
|
| 14:55 |
NEW APPROACHES TO DEFINING
MECHANISMS OF CYTOKINE DISREGULATION IN RHEUMATOID ARTHRITIS
M. Feldmann, B.M.J. Foxwell, S. Yoshimura, J. Bondeson, F.M.
Brennan, London, UK |
|
| 15:15 |
MECHANISMS OF TOLERANCE
INDUCTION AFTER BONE MARROW TRANSPLANTATION
M.G. Roncarolo, M. Levings, F. Galbiati, C. Sartirana, E. Zappone,
R. Bacchetta, Milano, Italy |
|
| 15:35 |
NEUROLOGICAL INJURY
H. Wekerle, Martinsried, Germany |
|
| 15:55 |
C o f f e e B r e a k |
|
| 16:15
- 17:55 |
HALL A
|
| |
S02: Satellite Symposium
Basic Science: From Mouse to Man
MECHANISTIC DIFFERENCES OF CORNERSTONE IMMUNOSUPPRESSANTS
Sponsored by: Fujisawa GmbH
L.C. Paul, Leiden, The Netherlands |
|
| 6:15 |
WELCOME AND INTRODUCTION
L.C. Paul, Leiden, The Netherlands |
|
| 16:25 |
ANTIBODY FORMATION AND ITS
IMPACT ON LONG-TERM OUTCOME AFTER TRANSPLANTATION
M.L. Rose, Middlesex, UK |
|
| 16:40 |
APOPTOSIS - FRIEND OR FOE?
B. Fellstrom, Uppsala, Sweden |
|
| 16:55 |
CORTICOSTEROID-SPARING AND
CORTICOSTEROID-MIMETIC EFFECTS: THE ROLE OF THE GLUCOCORTICOID
RECEPTOR
I. Brogan, Manchester, UK |
|
| 17:10 |
THE DIFFERENTIAL IMPACT OF
TACROLIMUS AND CICLOSPORIN ON P-GLYCOPROTEIN: POTENTIAL CLINICAL
IMPLICATIONS
T. van Gelder, Rotterdam, The Netherlands |
|
| 17:25 |
INTERLEUKIN-10 AND
ACUTE/CHRONIC REJECTION - GOOD OR BAD GUY?
H.D. Volk, Berlin, Germany |
|
| |
17:40 PANEL DUSCUSSION |
|
| 17:55
- 18:50 |
HALL A
|
| |
S02b: Satellite Symposium
Basic Science: From Mouse to Man (Cont.)
MALONONITRILAMIDES (MNAs) IN TRANSPLANTATION - A CLASS OF THEIR OWN
Sponsored by: Fujisawa GmbH
R.E. Morris, Stanford, CA, USA |
|
| |
17:55 MNAS: A CLASS OF THEIR
OWN
R.E. Morris, Stanford, USA |
|
| 18:10 |
DEVELOPMENT OF A NOVEL DRUG
FOR TRANSPLANTATION: CURRENT RESULTS AND FUTURE PERSPECTIVES
H.U. Schorlemmer, Marburg, Germany |
|
| 18:25 |
RESULTS FROM TOLERANCE
INDUCTION AND XENOTRANSPLANTATION
M. Waer, Leuven, Belgium |
|
| 18:40 |
PANEL DUSCUSSION |
|
|
